DIAGNOSTICS, BIOS, AND SOFTWARE CONTROLS Sample Clauses

DIAGNOSTICS, BIOS, AND SOFTWARE CONTROLS. Seller shall be required to demonstrate adequate controls over the distribution use of diagnostics, BIOS and the software shipping with the product. A program for the regular maintenance of diagnostics shall be required by Seller to ensure that a virus is not present in the Material. Revision controls for both the BIOS and the software shall be traceable to the serial number of the units. This information shall be maintained in the event of a change and conveyed to Buyer for field tracking purposes.
Sample 1
AutoNDA by SimpleDocs
DIAGNOSTICS, BIOS, AND SOFTWARE CONTROLS. Seller shall be required to demonstrate adequate controls over the distribution use of diagnostics, BIOS and the software shipping with the product. A program for the regular maintenance of diagnostics shall be required by Seller to ensure that a virus is not present in the Material. Revision controls for both the BIOS and the software shall be traceable to the serial number of the units. This information shall be maintained in the event of a change and conveyed to Buyer for field tracking purposes. <PAGE> 41 2.6 QUALITY SYSTEM PLAN Seller shall submit to Buyer for review and concurrence a Quality Manual and a Quality Control Plan, no later than [*] days prior to Seller's first scheduled production build. These documents shall define the Seller's overall Quality Assurance system elements, and detail inspection, test and audit points for manufacture of Buyer's Material. The Quality Manual shall demonstrate compliance to the applicable ISO 9000 Quality Systems series of standards, and shall identify any level of registration if achieved (ISO 9001, 9002, or 9003), by facility and location. Seller shall provide Buyer with a copy of any and all ISO 9000 certificates. The initial Supplier Quality Plan is included as Appendix 2 to this Exhibit. 2.7 MATERIAL ACCEPTANCE REQUIREMENTS Seller shall insure that Material delivered to Buyer's receiving facility meets all the requirements of: o Buyer's Purchase/Engineering Specification and [*] standards and requirements referenced therein. o Material marking per external agency requirements. o [*] o Material specific performance levels. o Compliance to then current European Economic Community standards and application of "CE" xxxx to product marking, as applicable. o Material protection against damage and loss. Seller shall make all Material acceptance data available to Buyer for review upon request. Seller shall, upon Buyer's request, hold initial shipments of Material until it is verified to be in compliance with Buyer's specifications. Seller shall not begin production or repair and distribution of spare or refurbished Material in this Exhibit to Buyer until their process has been assessed to have produced Material that meets the requirements of this Exhibit and as specified in the Technical Statement of Work supplied, if appropriate, with the Request for Quote. This assessment, applicable to all contracted Material unless agreed otherwise by Buyer, shall be performed by the Buyer or Buyer's authorized representative....
Sample 1

Related to DIAGNOSTICS, BIOS, AND SOFTWARE CONTROLS

  • Technology Discoveries, innovations, Know-How and inventions, whether patentable or not, including computer software, recognized under U.S. law as intellectual creations to which rights of ownership accrue, including, but not limited to, patents, trade secrets, maskworks and copyrights developed under this Agreement.

  • Licensed Software Computer program(s) provided by Contractor in connection with the Deliverables, subject to Section 14 of this Contract.

  • Third Party Software 1. The Software may contain third party software that requires and/or additional terms and conditions. Such required third party software notices and/or additional terms and conditions are located at xxxx://xxx.xxxxxxxxx.xxx/thirdparty/index.html and are made a part of and incorporated by reference into this XXXX. By accepting this XXXX, You are also accepting the additional terms and conditions, if any, set forth therein.

  • Clinical Data The descriptions of the results of any studies and tests conducted by or on behalf of, or sponsored by, the Company or its subsidiaries, or in which the Company has participated, that are described in the Disclosure Package and the Prospectus, or the results of which are referred to in the Disclosure Package and the Prospectus do not contain any misstatement of material fact or omit to state a material fact necessary to make such statements not misleading. The Company has no knowledge of any studies or tests not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Disclosure Package or Prospectus.

  • Hardware and Software Requirements In order to access and retain Disclosures electronically, you must satisfy the following computer hardware and software requirements: access to the Internet; an email account and related software capable of receiving email through the Internet; a web browser which is SSL-compliant and supports secure sessions, and hardware capable of running this software.

  • Computer Software The Grantee certifies that it has appropriate systems and controls in place to ensure that state funds will not be used in the performance of this Grant Agreement for the acquisition, operation, or maintenance of computer software in violation of copyright laws.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, Registration Statement, the Pricing Disclosure Package or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with applicable laws, rules, regulations and policies of the Food and Drug Administration of the U.S. Department of Health and Human Services (the “FDA”) or any committee thereof or of any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are materially inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement, the Pricing Disclosure Package or the Prospectus; for such studies that have been or are being conducted, the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by foreign government or drug or medical device regulatory agencies, or foreign health care facility Institutional Review Boards; and no investigational new drug application filed by or on behalf of the Company or any of its subsidiaries with the FDA has been terminated or suspended by the FDA, and neither the FDA nor any applicable foreign regulatory agency has commenced, or, to the knowledge of the Company, threatened to initiate, any action to place a clinical hold order on, or otherwise terminate, delay or suspend, any proposed or ongoing studies conducted or proposed to be conducted by or on behalf of the Company or any of its subsidiaries.

  • Information Technology The following applies to all contracts for information technology commodities and contractual services. “Information technology” is defined in section 287.012(15), F.S., to have the same meaning as provided in section 282.0041, F.S.

  • Background Technology List here prior contracts to assign Inventions that are now in existence between any other person or entity and you. [ ] List here previous Inventions which you desire to have specifically excluded from the operation of this Agreement. Continue on reverse side if necessary.

Time is Money Join Law Insider Premium to draft better contracts faster.